Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.Unknown journal · 2026-05-25A single dose of psilocybin eased depression symptoms for months, our study foundUnknown journal · 2026-05-21Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-14Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30Oregon’s Psilocybin Services: A summary and public health commentaryNew Prairie Press (Kansas State University) · 2026-04-16A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-08Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-07Psilocybin: Chemical Foundations and Emerging Therapeutic PotentialMini-Reviews in Medicinal Chemistry · 2026-03-23Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase developmentJournal of Drug Delivery Science and Technology · 2026-03-09Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-08Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intakeJournal of Analytical Toxicology · 2026-02-18Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.The International journal on drug policy · 2026-01-31Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-11Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacinNeuroscience Applied · 2025-12-31Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trialNeuroscience Applied · 2025-12-31Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depressionNeuroscience Applied · 2025-12-31A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use DisorderPsychedelic Medicine · 2025-12-25Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-18Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol DevelopmentPreprints.org · 2025-12-18Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyBJPsych Open · 2025-12-14Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational StudyResearch Square · 2025-12-09Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in SwitzerlandmedRxiv · 2025-11-30Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticityBiomedicine & Pharmacotherapy · 2025-10-29Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Unknown journal · 2025-10-15Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-09-30Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspringNature Communications · 2025-09-29Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyComprehensive Psychiatry · 2025-07-01Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.Unknown journal · 2025-06-30Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.Unknown journal · 2025-06-23Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategyEuropean Journal of Medicinal Chemistry Reports · 2025-06-02Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatmentsPsyArXiv · 2025-05-15Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg s Archives of Pharmacology · 2025-04-14Pharmacokinetics of Psilocybin: A Systematic Review.Unknown journal · 2025-03-24Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic PropertiesJournal of Medicinal Chemistry · 2025-03-19Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.Unknown journal · 2025-02-28Development of Psilocybe Mushroom Species Reference Material-Cultivation Parameters and Chemical ProfilesJournal of AOAC International · 2025-02-12Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Unknown journal · 2025-01-29Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21Does psilocybin really provide long-term relief from depression, as new study suggests?Unknown journal · 2024-10-01From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.PsyArXiv · 2024-09-30From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.PsyArXiv · 2024-09-30Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humansmedRxiv · 2024-09-21The Black Book of Psychotropic Dosing and Monitoring.Unknown journal · 2024-06-30Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushroomsBritish Journal of Pharmacology · 2024-06-01Structural pharmacology and therapeutic potential of 5-methoxytryptamines.Unknown journal · 2024-05-07[Psychedelic psychiatry].Unknown journal · 2024-04-03Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.Psychological medicine · 2024-03-31Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Unknown journal · 2024-01-10Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybinJournal of Drug Delivery Science and Technology · 2024-01-05Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping ReviewbioRxiv · 2024-01-04IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.Pharmacological research · 2023-12-31Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.Journal of psychopharmacology (Oxford, England) · 2023-12-31Is Poorly Assisted Psilocybin Treatment an Increasing Risk?Unknown journal · 2023-12-31[The nursing role in psychedelic-assisted psychotherapy].Revue de l'infirmiere · 2023-12-31Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Unknown journal · 2023-12-14Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-22Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorderFrontiers in Psychiatry · 2023-09-17Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment DevelopmentPsychedelic Medicine · 2023-09-05Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Unknown journal · 2023-08-23Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.Unknown journal · 2023-07-22A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolUnknown journal · 2023-07-18Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybinbioRxiv · 2023-04-13Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.Unknown journal · 2023-04-01Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.Journal of affective disorders · 2023-03-31Classic psychedelic use and current meditation practice.Mindfulness · 2023-03-31National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.Unknown journal · 2023-02-26Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2022-12-31Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.Journal of psychoactive drugs · 2022-12-31Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.Frontiers in psychology · 2022-12-31The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness.Journal of psychoactive drugs · 2022-12-31Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patientsJournal of Affective Disorders · 2022-12-09A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Unknown journal · 2022-10-02Prevalence and associations of classic psychedelic-related seizures in a population-based sample.Drug and alcohol dependence · 2022-09-30Psychedelics for Alzheimer's Disease Palliative Care.Advances in psychiatry and behavioral health · 2022-08-31Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Unknown journal · 2022-08-16Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.Unknown journal · 2022-08-12How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.Psychopharmacology · 2022-05-31Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2021-12-31Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.Current topics in behavioral neurosciences · 2021-12-31Classic psychedelics, health behavior, and physical health.Therapeutic advances in psychopharmacology · 2021-12-31Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2021-12-31Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.Unknown journal · 2021-07-26Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences.The International journal on drug policy · 2020-12-31Ethical Concerns about Psilocybin Intellectual Property.ACS Pharmacology & Translational Science · 2020-12-31Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.Unknown journal · 2020-11-03The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.Unknown journal · 2020-01-01Enzymatic Route toward 6-Methylated Baeocystin and PsilocybinChemBioChem · 2019-05-30The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-07-31Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogensbioRxiv · 2018-07-23Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.Frontiers in Pharmacology · 2018-07-04Psilocybin for treating substance use disorders?Unknown journal · 2016-08-11Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.Unknown journal · 2013-05-22[Suicide under the influence of "magic mushrooms"].PubMed · 2013-04-30Effects of psilocybin on time perception and temporal control of behaviour in humans.Queensland's institutional digital repository (The University of Queensland) · 2006-05-18Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.Unknown journal · 2003-11-12P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosisEuropean Neuropsychopharmacology · 2003-09-30Jekyll and Hyde revisited: paradoxes in the appreciation of drug experiences and their effects on creativity.Unknown journal · 2002-06-30Hallucinogenic drugs attenuate the subjective response to alcohol in humans.Unknown journal · 2000-09-30Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro StudiesInternational journal of medicinal mushrooms · 1999-12-31Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.Unknown journal · 1999-05-31[A caution for psilocybine in wild mushrooms. A young addict acquired acute delirium].Unknown journal · 1995-09-30Comparison of the discriminative stimulus properties of delta9-THC and psilocybin in rats.Unknown journal · 1975-08-31CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.Unknown journal · 1964-05-31